Skip Navigation


Rheumatology Advance Access originally published online on August 3, 2004
Rheumatology 2004 43(12):1473-1475; doi:10.1093/rheumatology/keh338
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/12/1473    most recent
keh338v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smith, R.
Right arrow Articles by Mace, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R.
Right arrow Articles by Mace, A.
Related Collections
Right arrow Education
Right arrow Pharmacology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 12 © British Society for Rheumatology 2004; all rights reserved

REVIEW

Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines

R. Smith, L. Barnsley, S. Kannangara and A. Mace1

New South Wales Institute of Sports Medicine, Concord Hospital, Sydney, Australia and 1 Department of Otolaryngology, Charing Cross Hospital, London, UK.

Correspondence to: L. Barnsley, New South Wales Institute of Sports Medicine and Department of Rheumatology, Concord Hospital, NSW 2139, Australia. E-mail: les.barnsley{at}email.cs.nsw.gov.au

Rheumatologists, with their musculoskeletal background, often care for athletes. The effect of a positive anti-doping test, whether through illegitimate use or accidental prescribing of banned drugs, is devastating to an athlete's career. It is therefore incumbent upon rheumatologists to be aware of issues relating to drugs in sport. This involves both therapeutic drugs and doping. It is vital to ensure that any substance prescribed should be approved for use and should not adversely affect (or benefit) the athlete's performance. In March 2004, 5 months prior to the 2004 Olympic Games in Athens, the joint World Anti-Doping Agency/International Olympic Committee published the revised list of banned substances in athletes. This article aims to provide an overview of the current status of medications commonly prescribed in rheumatological practice.

KEY WORDS: Rheumatology, WADA (World Anti-Doping Agency), IOC (International Olympic Committee), Doping


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.